121
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital

, &
Pages 31-38 | Published online: 24 Mar 2015

References

  • WalkerBBarrettSPolaskySEnvironment. Looming global scale failures and missing institutionsScience20093251345134619745137
  • CaldwellRLindbergDUnderstanding evolution: mutations are random [webpage on the Internet]University of California Museum of Paleontology Available from: http://evolution.berkeley.edu/evolibrary/article/mutations_07Accessed January 22, 2015
  • HawkeyPMJonesAMThe changing epidemiology of resistanceJ Antimicrob Chemother200964Suppl 1i3i1019675017
  • PechèreJCPatients’ interviews and misuse of antibioticsClin Infect Dis200133Suppl 3S170S17311524715
  • SpellbergBBlaserMGuidosRCombating antimicrobial resistance: policy recommendations to save livesClin Infect Dis201152Suppl 5S397S42821474585
  • ZilberbergMDChenJModySHRamseyAMShorrAFImipenem resistance of Pseudomonas in pneumonia: a systematic literature reviewBMC Pulm Med20102410
  • National Nosocomial Infections Surveillance SystemNational Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004Am J Infect Control20043247015573054
  • ObritschMDFishDNMacLarenRJungRNational surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002Antimicrob Agents Chemother2004484606461015561832
  • ArajGFZaatariGSAntimicrobial Susceptibility Patterns of Bacterial Isolates at American Universityof Beirut Medical CenterBeyrouthWyeth Pharmaceuticals2001
  • SlamaTGGram-negative antibiotic resistance: there is a price to payCrit Care200812Suppl 4S418495061
  • Centers for Disease Control and PreventionAcinetobacter baumannii infections among patients at military medical facilities treating injured US service members, 2002–2004MMWR Morb Mortal Wkly Rep200453451063106615549020
  • TalbotGHBradleyJEdwardsJEJrGilbertDScheldMBarlettJGAntimicrobial Availability Task Force of the Infectious Diseases Society of America: bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaClin Infect Dis20064265766816447111
  • LambertPAMechanisms of antibiotic resistance in Pseudomonas aeruginosaJ Roy Soc Med200295Suppl 41222612216271
  • GaynesREdwardsJRNational Nosocomial Infections Surveillance System: overview of nosocomial infections caused by gram-negative bacilliClin Infect Dis20054184885416107985
  • ClissoldSPToddPACampoli-RichardsDMImipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacyDrugs1987331832413552595
  • BuckleyMMBrogdenRNBarradellLBGoaKLImipenem/cilastatin: a reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacyDrugs1992444084441382937
  • ShivaASalehifarEAminiMDrug utilization evaluation of imipenem in an educational hospital in Mazandaran ProvinceJ Pharm Sci20142011217
  • SakhaiyanEHadjibabaieMGholamiKDrug utilization evaluation of imipenem in patients undergoing bone marrow transplantationInt J Hematol Oncol Stem Cell Res2009321013
  • BrothrtonTJKelberRLSeizure-like activity associated with imipenemClin Pharmacy19843536540
  • EngRHMunsifANYongcoBGSeizure propensity with imipenemArch Intern Med1989149188118832669668
  • LeoRJBallowCHSeizure activity associated with imipenem use: clinical case reports and review of the literatureAnn Pharmacother199125351354
  • CalandraGLydickECarriganJFactors predisposing to seizures in seriously ill, infected patients receiving antibiotics: experience with imipenem/cilastatinAm J Med1988849119183284342
  • GuptaKHootonTMNaberKGInternational clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClin Infect Dis2011525e103e12021292654
  • FreifeldAGBowEJSepkowitzKAClinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of AmericaClin Infect Dis2011524e56e9321258094
  • StevensDLBisnoALChambersHFPractice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of AmericaClin Infect Dis2014592e10e5224973422
  • LipskyBABerendtARCorniaPBInfectious Diseases Society of AmericaExecutive summary: 2012 Infectious Diseases Society of America practice guideline for the diagnosis and treatment of diabetic foot infectionsClin Inect Dis20125416791684
  • SolomkinJSMazuskiJEBradleyJSDiagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of AmericaClin Infect Dis20105013316420034345
  • DellingerRPLevyMMRhodesASurviving Sepsis Campaign Guidelines Committee Including the Pediatric SubgroupSurviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012Crit Care Med201341258063723353941
  • The Merck ManualImipenem and cilastatin [webpage on the Internet] Lexi-CompMerck & Co., Inc2013 Available from: http://www.merckmanuals.com/professional/print/lexicomp/imipenem%20and%20cilastatin.html?qt=idarubicin&alt=shAccessed January 22, 2015
  • RxListPrimaxin IV (imipenem and cilastatin) for injection [webpage on the Internet] Available from: http://www.rxlist.com/primaxin-iv-drug.htmAccessed January 22, 2015
  • McAuleyDImipenem/cilastatin Primaxin® renal dosing [webpage on the Internet] Available from: http://www.globalrph.com/imipenem_renal.htmAccessed January 22, 2015
  • FicaCALuppiMMOlivaresCRBritoFLZillerueloLIMuñozCLImipenem-cilastatin use in a university hospital in ChileRev Chilena Infectol200623430731517186077
  • Imipenem [package insert]Whitehouse Station, NJMerck & Co2007 Available from: http://www.globalrph.com/imipenem_dilution.htmAccessed January 22, 2015
  • PastelDAImipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combinationClin Pharm198657197363530614
  • ThuongMShortgenFZazempaVAppropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluationJ Antimicrob Chemother200046350150810980183
  • PakyzALOinonenMPolkRERelationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosaAntimicrob Agents Chemother20095351983198619273670
  • XueXSWangBDengLJKangYCarbapenem restriction reduce the incidence of multidrug-resistant Acinetobacter baumannii in ventilator associated pneumoniaChin Crit Care Med2009214234236 Chinese
  • KaboliPHothAMcClimonBClinical pharmacists and inpatient medical care: a systematic reviewArch Intern Med200616695596416682568